Back to Top
Go Back
Journal Photo for Psychiatry Research
Peer reviewed only Open Access

Psychiatry Research (PR)

Publisher : Elsevier Ltd
Biological Psychiatry Mental Health
e-ISSN 1872-7123
p-ISSN 0165-1781
Issue Frequency Monthly
Impact Factor 4.2
Est. Year 2006
Mobile 4401865843000
Country United Kingdom
Language English
APC YES
Impact Factor Assignee Google Scholar
Email journalscustomerserviceEMEA@elsevier.com

Journal Descriptions

This journal provides rapid publication of complete research reports and reviews in the field of psychiatry. The scope of the journal encompasses: Biochemical, physiological, neuroanatomic, genetic, neurocognitive, and psychosocial determinants of psychiatric disorders. Diagnostic assessments of psychiatric disorders. Evaluations that pursue hypotheses about the cause or causes of psychiatric diseases. Evaluations of pharmacologic and non-pharmacologic psychiatric treatments. Basic neuroscience studies related to animal or neurochemical models for psychiatric disorders. Methodological advances, such as instrumentation, clinical scales, and assays directly applicable to psychiatric research. These will be considered only if the scales and assays are included as an appendix to the manuscript in English. If they are too long, the way to obtain them without cost to the reader must be carefully stated in the methods section of the manuscript.

Psychiatry Research (PR) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Biological, Psychiatry, Mental Health, Neuroscience , Online or Print , Monthly Journal

  • UGC Approved, ISSN Approved: P-ISSN P-ISSN: 0165-1781, E-ISSN: 1872-7123, Established: 2006, Impact Factor: 4.2
  • Does Not Provide Crossref DOI
  • Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE

Indexing

Publications of PR

Peter B Jones April, 2018
Poor social functioning has been found to be present in those at risk for psychosis. This study aimed to examine metacognitive beliefs as potential predictors of structured activity (measure...
Peter B Jones March, 2018
It is still unclear to what extent personality may influence the development of psychosis. We aimed to explore significant personality traits in individuals at high-risk (HR) for psychosis. ...
Graham Murray January, 2017
This naturalistic study analysed the association between cumulative lifetime antipsychotic dose and cognition in schizophrenia after an average of 16.5 years of illness. Sixty participants w...
Roy F. Baumeister October, 2020
The coronavirus disease 2019 (COVID-19) pandemic can have a profound impact on the mental health of patients who survived the illness. However, little is known about the prevalence rate of m...